UBS Upgrades Genzyme (GENZ) to Buy, Boosts Target to $68
Tweet Send to a Friend
UBS upgrades Genzyme (Nasdaq: GENZ) from Neutral to Buy. The firm also raised ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


